Integrated Filing — IndAS

General information about company
Scrip Code	531335
NSE Symbol	ZYDUSWELL
MSEI Symbol	NOTLISTED
ISIN	INE768C01010
Name of company	ZYDUS WELLNESS LIMITED
Type of company	Main Board
Class of security	Equity
Date of start of financial year	01-Apr-2024
Date of end of financial year	31-Mar-2025
Date of board meeting when results were approved	19-May-2025
Date on which prior intimation of the meeting for considering financial results was informed to the exchange	09-May-2025
Description of presentation currency	INR (in Actuals)
Reporting Type	Quarterly
Reporting Quarter	Fourth quarter
Nature of report standalone or consolidated	Consolidated
Whether results are audited or unaudited for the quarter ended	Unaudited
Whether results are audited or unaudited for the Year to date for current period ended/year ended	Audited
Segment Reporting	Single segment
Description of single segment	Consumer Products
Start date and time of board meeting	19-May-2025   11:15:00
End date and time of board meeting	19-May-2025   12:30:00
Whether cash flow statement is applicable on company	Yes
Type of cash flow statement	Cash Flow Indirect
Declaration of unmodified opinion or statement on impact of audit qualification	Declaration of unmodified opinion

Financial Results Ind-AS
Particulars		3 months/ 6 months ended (dd-mm-yyyy)	Year to date figures for current period ended (dd-mm-yyyy)
A	Date of start of reporting period	01-Jan-2025	01-Apr-2024
B	Date of end of reporting period	31-Mar-2025	31-Mar-2025
C	Whether results are audited or unaudited	Unaudited	Audited
D	Nature of report standalone or consolidated	Consolidated	Consolidated
Part I	Blue color marked fields are non-mandatory. For Consolidated Results, if the company has no figures for 3 months / 6 months ended, in such case zero shall be inserted in the said column.
1	Income
	Revenue from operations	9131000000	27089000000
	Other income	8000000	136000000
	Total income	9139000000	27225000000
2	Expenses
(a)	Cost of materials consumed	4338000000	11845000000
(b)	Purchases of stock-in-trade	685000000	1440000000
(c)	Changes in inventories of finished goods, work-in-progress and stock-in-trade	-906000000	-504000000
(d)	Employee benefit expense	733000000	2372000000
(e)	Finance costs	42000000	120000000
(f)	Depreciation, depletion and amortisation expense	132000000	284000000
(f)	Other Expenses
1	Advertisement and promotion expenses	1080000000	3543000000
2	Other expenses	1296000000	4595000000
3	Net loss/ [gain] on foreign currency transactions	5000000	1000000
	Total other expenses	2381000000	8139000000
	Total expenses	7405000000	23696000000
3	Total profit before exceptional items and tax	1734000000	3529000000
4	Exceptional items	0	59000000
5	Total profit before tax	1734000000	3588000000
6	Tax expense
7	Current tax	-1000000	2000000
8	Deferred tax	16000000	117000000
9	Total tax expenses	15000000	119000000
10	Net movement in regulatory deferral account balances related to profit or loss and the related deferred tax movement	0	0
11	Net Profit Loss for the period from continuing operations	1719000000	3469000000
12	Profit (loss) from discontinued operations before tax	0	0
13	Tax expense of discontinued operations	0	0
14	Net profit (loss) from discontinued operation after tax	0	0
15	Share of profit (loss) of associates and joint ventures accounted for using equity method	0	0
16	Total profit (loss) for period	1719000000	3469000000
17	Other comprehensive income net of taxes	-6000000	-10000000
18	Total Comprehensive Income for the period	1713000000	3459000000
19	Total profit or loss, attributable to
	Profit or loss, attributable to owners of parent	1719000000	3469000000
	Total profit or loss, attributable to non-controlling interests	0	0
20	Total Comprehensive income for the period attributable to
	Comprehensive income for the period attributable to owners of parent	-6000000	-10000000
	Total comprehensive income for the period attributable to owners of parent non-controlling interests	1713000000	3459000000
21	Details of equity share capital
	Paid-up equity share capital	636000000	636000000
	Face value of equity share capital	10	10
27	Details of debt securities
22	Reserves excluding revaluation reserve		56080000000
23	Earnings per share
i	Earnings per equity share for continuing operations
	Basic earnings (loss) per share from continuing operations	27.01	54.52
	Diluted earnings (loss) per share from continuing operations	27.01	54.52
ii	Earnings per equity share for discontinued operations
	Basic earnings (loss) per share from discontinued operations	0	0
	Diluted earnings (loss) per share from discontinued operations	0	0
ii	Earnings per equity share
	Basic earnings (loss) per share from continuing and discontinued operations	27.01	54.52
	Diluted earnings (loss) per share from continuing and discontinued operations	27.01	54.52
24	Debt equity ratio
25	Debt service coverage ratio
26	Interest service coverage ratio
27	Disclosure of notes on financial results

Remarks
Debt equity ratio
Debt service coverage ratio
Interest service coverage ratio

Statement of Asset and Liabilities
Particulars		Year ended (dd-mm-yyyy)
Date of start of reporting period		01-Apr-2024
Date of end of reporting period		31-Mar-2025
Whether results are audited or unaudited		Audited
Nature of report standalone or consolidated		Consolidated
	Assets
1	Non-current assets
	Property, plant and equipment	2904000000
	Capital work-in-progress	151000000
	Investment property	0
	Goodwill	40105000000
	Other intangible assets	8240000000
	Intangible assets under development	0
	Biological assets other than bearer plants	0
	Investments accounted for using equity method	0
	Non-current financial assets
	Non-current investments	7000000
	Trade receivables, non-current	0
	Loans, non-current	0
	Other non-current financial assets	46000000
	Total non-current financial assets	53000000
	Deferred tax assets (net)	1447000000
	Other non-current assets	477000000
	Total non-current assets	53377000000
2	Current assets
	Inventories	5175000000
	Current financial asset
	Current investments	357000000
	Trade receivables, current	3670000000
	Cash and cash equivalents	667000000
	Bank balance other than cash and cash equivalents	72000000
	Loans, current	13000000
	Other current financial assets	198000000
	Total current financial assets	4977000000
	Current tax assets (net)	0
	Other current assets	890000000
	Total current assets	11042000000
3	Non-current assets classified as held for sale	0
4	Regulatory deferral account debit balances and related deferred tax Assets	0
	Total assets	64419000000
	Equity and liabilities
1	Equity
	Equity attributable to owners of parent
	Equity share capital	636000000
	Other equity	56080000000
	Total equity attributable to owners of parent	56716000000
	Non controlling interest	0
	Total equity	56716000000
2	Liabilities
	Non-current liabilities
	Non-current financial liabilities
	Borrowings, non-current	0
	Trade payables, non-current
	(A) Total outstanding dues of micro enterprises and small enterprises	0
	(B) Total outstanding dues of creditors other than micro enterprises and small enterprises	0
	Total Trade payable	0
	Other non-current financial liabilities	32000000
	Total non-current financial liabilities	32000000
	Provisions, non-current	212000000
	Deferred tax liabilities (net)	0
	Deferred government grants, Non-current	0
	Other non-current liabilities	4000000
	Total non-current liabilities	248000000
	Current liabilities
	Current financial liabilities
	Borrowings, current	1850000000
	Trade payables, current
	(A) Total outstanding dues of micro enterprises and small enterprises	493000000
	(B) Total outstanding dues of creditors other than micro enterprises and small enterprises	3795000000
	Total Trade payable	4288000000
	Other current financial liabilities	374000000
	Total current financial liabilities	6512000000
	Other current liabilities	497000000
	Provisions, current	446000000
	Current tax liabilities (Net)	0
	Deferred government grants, Current	0
	Total current liabilities	7455000000
3	Liabilities directly associated with assets in disposal group classified as held for sale	0
4	Regulatory deferral account credit balances and related deferred tax liability	0
	Total liabilities	7703000000
	Total equity and liabilites	64419000000
	Disclosure of notes on assets and liabilities

Format for Reporting Segmenet wise Revenue, Results and Capital Employed along with the company results
Particulars		3 months/ 6 month ended (dd-mm-yyyy)	Year to date figures for current period ended (dd-mm-yyyy)
Date of start of reporting period		01-Jan-2025	01-Apr-2024
Date of end of reporting period		31-Mar-2025	31-Mar-2025
Whether accounts are audited or unaudited		Unaudited	Audited
Nature of report standalone or consolidated		Consolidated	Consolidated
1	Segment Revenue (Income)
	(net sale/income from each segment should be disclosed)
	Total Segment Revenue
	Less: Inter segment revenue
	Revenue from operations
2	Segment Result
	Profit (+) / Loss (-) before tax and interest from each segment
	Total Profit before tax
	i. Finance cost
	ii. Other Unallocable Expenditure net off Unallocable income
	Profit before tax
3	(Segment Asset - Segment Liabilities)
	Segment Asset
	Total Segment Asset
	Un-allocable Assets	null	null
	Net Segment Asset	null	null
4	Segment Liabilities
	Segment Liabilities
	Total Segment Liabilities
	Un-allocable Liabilities	null	null
	Net Segment Liabilities	null	null
	Disclosure of notes on segments

Other Comprehensive Income
Particulars		3 months/ 6 months ended (dd-mm-yyyy)	Year to date figures for current period ended (dd-mm-yyyy)
A	Date of start of reporting period	01-Jan-2025	01-Apr-2024
B	Date of end of reporting period	31-Mar-2025	31-Mar-2025
C	Whether results are audited or unaudited	Unaudited	Audited
D	Nature of report standalone or consolidated	Consolidated	Consolidated
	Other comprehensive income [Abstract]
1	Amount of items that will not be reclassified to profit and loss
1	Re-measurement loss on post employment defined benefit plans	-10000000	-6000000
	Total Amount of items that will not be reclassified to profit and loss	-10000000	-6000000
2	Income tax relating to items that will not be reclassified to profit or loss	-2000000	-1000000
3	Amount of items that will be reclassified to profit and loss
1	Exchange differences on transaction of financial statement of a foreign operations	2000000	-5000000
	Total Amount of items that will be reclassified to profit and loss	2000000	-5000000
4	Income tax relating to items that will be reclassified to profit or loss	0	0
5	Total Other comprehensive income	-6000000	-10000000

Cash flow statement, indirect
Particulars				Year ended (dd-mm-yyyy)
A	Date of start of reporting period			2024-04-01
B	Date of end of reporting period			2025-03-31
C	Whether results are audited or unaudited			Unaudited
D	Nature of report standalone or consolidated			Consolidated
Part I	Blue color marked fields are non-mandatory.
	Statement of cash flows
	Cash flows from used in operating activities
	Profit before tax			3588000000
	Adjustments for reconcile profit (loss)
	Adjustments for finance costs			120000000
	Adjustments for decrease (increase) in inventories			-398000000
	Adjustments for decrease (increase) in trade receivables, current			-653000000
	Adjustments for decrease (increase) in trade receivables, non-current			0
	Adjustments for decrease (increase) in other current assets			353000000
	Adjustments for decrease (increase) in other non-current assets			0
	Adjustments for other financial assets, non-current			0
	Adjustments for other financial assets, current			0
	Adjustments for other bank balances			0
	Adjustments for increase (decrease) in trade payables, current			513000000
	Adjustments for increase (decrease) in trade payables, non-current			0
	Adjustments for increase (decrease) in other current liabilities			-83000000
	Adjustments for increase (decrease) in other non-current liabilities			0
	Adjustments for depreciation and amortisation expense			284000000
	Adjustments for impairment loss reversal of impairment loss recognised in profit or loss			0
	Adjustments for provisions, current			170000000
	Adjustments for provisions, non-current			0
	Adjustments for other financial liabilities, current			0
	Adjustments for other financial liabilities, non-current			0
	Adjustments for unrealised foreign exchange losses gains			2000000
	Adjustments for dividend income			0
	Adjustments for interest income			31000000
	Adjustments for share-based payments			0
	Adjustments for fair value losses (gains)			0
	Adjustments for undistributed profits of associates			0
	Other adjustments for which cash effects are investing or financing cash flow			-94000000
	Other adjustments to reconcile profit (loss)			0
	Other adjustments for non-cash items			0
	Share of profit and loss from partnership firm or association of persons or limited liability partnerships			0
	Total adjustments for reconcile profit (loss)			183000000
	Net cash flows from (used in) operations			3771000000
	Dividends received			0
	Interest paid			0
	Interest received			0
	Income taxes paid (refund)			-29000000
	Other inflows (outflows) of cash			0
	Net cash flows from (used in) operating activities			3800000000
	Cash flows from used in investing activities
	Cash flows from losing control of subsidiaries or other businesses			2000000
	Cash flows used in obtaining control of subsidiaries or other businesses			3690000000
	Other cash receipts from sales of equity or debt instruments of other entities			0
	Other cash payments to acquire equity or debt instruments of other entities			0
	Other cash receipts from sales of interests in joint ventures			0
	Other cash payments to acquire interests in joint ventures			0
	Cash receipts from share of profits of partnership firm or association of persons or limited liability partnerships			0
	Cash payment for investment in partnership firm or association of persons or limited liability partnerships			0
	Proceeds from sales of property, plant and equipment			10000000
	Purchase of property, plant and equipment			663000000
	Proceeds from sales of investment property			0
	Purchase of investment property			0
	Proceeds from sales of intangible assets			0
	Purchase of intangible assets			0
	Proceeds from sales of intangible assets under development			0
	Purchase of intangible assets under development			0
	Proceeds from sales of goodwill			0
	Purchase of goodwill			0
	Proceeds from biological assets other than bearer plants			0
	Purchase of biological assets other than bearer plants			0
	Proceeds from government grants			0
	Proceeds from sales of other long-term assets			0
	Purchase of other long-term assets			0
	Cash advances and loans made to other parties			0
	Cash receipts from repayment of advances and loans made to other parties			1000000
	Cash payments for future contracts, forward contracts, option contracts and swap contracts			0
	Cash receipts from future contracts, forward contracts, option contracts and swap contracts			0
	Dividends received			0
	Interest received			31000000
	Income taxes paid (refund)			0
	Other inflows (outflows) of cash			2073000000
	Net cash flows from (used in) investing activities	-2236000000
	Cash flows from used in financing activities
	Proceeds from changes in ownership interests in subsidiaries			0
	Payments from changes in ownership interests in subsidiaries			0
	Proceeds from issuing shares			0
	Proceeds from issuing other equity instruments			0
	Payments to acquire or redeem entity's shares			0
	Payments of other equity instruments			0
	Proceeds from exercise of stock options			0
	Proceeds from issuing debentures notes bonds etc			0
	Proceeds from borrowings			0
	Repayments of borrowings			1390000000
	Payments of lease liabilities			19000000
	Dividends paid			318000000
	Interest paid			136000000
	Income taxes paid (refund)			0
	Other inflows (outflows) of cash			0
	Net cash flows from (used in) financing activities			-1863000000
	Net increase (decrease) in cash and cash equivalents before effect of exchange rate changes			-299000000
	Effect of exchange rate changes on cash and cash equivalents
	Effect of exchange rate changes on cash and cash equivalents			0
	Net increase (decrease) in cash and cash equivalents			-299000000
	Cash and cash equivalents cash flow statement at beginning of period			966000000
	Cash and cash equivalents cash flow statement at end of period			667000000